Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Bendazac L-lysine

Copy Product Info
🥰Excellent
Catalog No. T3141Cas No. 81919-14-4
Alias Bendazaco lisina, Bendazac lysine

Bendazac L-lysine (Bendazaco lisina) is an agent introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.

Bendazac L-lysine

Bendazac L-lysine

Copy Product Info
🥰Excellent
Purity: 99.85%
Catalog No. T3141Alias Bendazaco lisina, Bendazac lysineCas No. 81919-14-4
Bendazac L-lysine (Bendazaco lisina) is an agent introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
200 mg$33In StockIn Stock
500 mg$55In StockIn Stock
1 g$79In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.85%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bendazac L-lysine AI Summary
Bendazac L-lysine exhibits bioactivities related to anticataract activity against FeCl3/H2O2-induced cataract in both rabbit and rat lenses. At a concentration of 0.5 mM, it shows varying degrees of activity ranging from 0% to 75%. At a 5 mM concentration, the compound induces water-solvent protein levels and reduces malondialdehyde levels in rabbit lens homogenates, while having a minimal impact on the total antioxidant capacity in the same homogenates. Additionally, Bendazac L-lysine demonstrates good aqueous solubility, with a solubility of 93.8 μg/mL..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Bendazac L-lysine (Bendazaco lisina) is an agent introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.
SynonymsBendazaco lisina, Bendazac lysine
Chemical Properties
Molecular Weight428.48
FormulaC22H28N4O5
Cas No.81919-14-4
SmilesO(c1nn(c2c1cccc2)Cc1ccccc1)CC(=O)O.OC(=O)[C@@H](N)CCCCN
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 2.41 mg/mL (5.62 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3338 mL11.6692 mL23.3383 mL116.6916 mL
5 mM0.4668 mL2.3338 mL4.6677 mL23.3383 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Bendazac L-lysine | purchase Bendazac L-lysine | Bendazac L-lysine cost | order Bendazac L-lysine | Bendazac L-lysine chemical structure | Bendazac L-lysine formula | Bendazac L-lysine molecular weight